Hydrocortisone Butyrate Patent Expiration

Hydrocortisone Butyrate was first introduced by Bausch Health Us Llc in its drug Locoid on Mar 31, 1982. Another drug containing Hydrocortisone Butyrate is Locoid Lipocream. 9 different companies have introduced drugs containing Hydrocortisone Butyrate.


Hydrocortisone Butyrate Patents

Given below is the list of patents protecting Hydrocortisone Butyrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Locoid US7378405 Stabilized steroid composition and method for its preparation Dec 19, 2026 Bausch
Locoid US7981877 Stabilized steroid composition and method for its preparation Jan 23, 2025

(Expired)

Bausch
Locoid Lipocream US5635497 Topical application compositions Jun 03, 2014

(Expired)

Precision Dermat



Hydrocortisone Butyrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydrocortisone Butyrate Generic API Manufacturers

Several generic applications have been filed for Hydrocortisone Butyrate. The first generic version for Hydrocortisone Butyrate was by Taro Pharmaceutical Industries Ltd and was approved on Jan 14, 2004. And the latest generic version is by Lupin Ltd and was approved on Aug 17, 2018.

Given below is the list of companies who have filed for Hydrocortisone Butyrate generic, along with the locations of their manufacturing plants worldwide.